Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to mani...
Hlavní autoři: | Yan-Ruide Li, Tyler Halladay, Lili Yang |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
BMC
2024-01-01
|
Edice: | Journal of Biomedical Science |
Témata: | |
On-line přístup: | https://doi.org/10.1186/s12929-024-00998-8 |
Podobné jednotky
-
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
Autor: Yan-Ruide Li, a další
Vydáno: (2022-05-01) -
Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
Autor: Abigail Cheever, a další
Vydáno: (2022-11-01) -
CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
Autor: Ler Yie Chan, a další
Vydáno: (2022-03-01) -
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
Autor: John A. Ligon, a další
Vydáno: (2022-02-01) -
The Emergence of Universal Immune Receptor T Cell Therapy for Cancer
Autor: Nicholas G. Minutolo, a další
Vydáno: (2019-03-01)